Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder

Abstract Background Buprenorphine is an effective and safe treatment for opioid use disorder, but the requirement for moderate opioid withdrawal symptoms to emerge prior to initiation is a significant treatment barrier. Case Presentation We report on two cases of hospitalized patients with severe, a...

Descripció completa

Dades bibliogràfiques

Autors principals:	Pouya Azar, Hannah Schneiderman, Henry Barron, James S. H. Wong, Maximilian Meyer, Dayyon Newman-Azar, Matin Narimani, Martha J. Ignaszewski, Nickie Mathew, Rodney Mullen, Reinhard M. Krausz, Anil R. Maharaj
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2024-06-01
Col·lecció:	Addiction Science & Clinical Practice
Matèries:	Low-dose induction Micro-induction Micro-dosing buprenorphine Transdermal Subcutaneous Butrans
Accés en línia:	https://doi.org/10.1186/s13722-024-00479-1
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!